Opaleye Management as of Sept. 30, 2016
Portfolio Holdings for Opaleye Management
Opaleye Management holds 44 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Blueprint Medicines (BPMC) | 12.2 | $23M | 785k | 29.70 | |
| Axogen (AXGN) | 9.4 | $18M | 2.0M | 9.03 | |
| Ariad Pharmaceuticals | 7.5 | $14M | 1.0M | 13.69 | |
| Medgenics | 5.2 | $10M | 1.8M | 5.57 | |
| Agios Pharmaceuticals (AGIO) | 3.6 | $6.9M | 130k | 52.82 | |
| Fibrogen (FGEN) | 3.6 | $6.8M | 330k | 20.70 | |
| Foamix Pharmaceuticals | 3.0 | $5.8M | 630k | 9.26 | |
| Cara Therapeutics (CARA) | 3.0 | $5.6M | 675k | 8.35 | |
| Codexis (CDXS) | 2.7 | $5.2M | 1.2M | 4.44 | |
| Cynapsus Therapeutics | 2.6 | $5.0M | 125k | 40.23 | |
| Horizon Pharma | 2.6 | $5.0M | 275k | 18.13 | |
| Eagle Pharmaceuticals (EGRX) | 2.6 | $4.9M | 70k | 70.00 | |
| Imprimis Pharmaceuticals | 2.4 | $4.6M | 1.2M | 3.81 | |
| Protalix Biotherapeutics Inc note 4.500% 9/1 | 2.4 | $4.6M | 8.1M | 0.57 | |
| Global Blood Therapeutics In | 2.4 | $4.6M | 200k | 23.05 | |
| Macrogenics (MGNX) | 2.3 | $4.3M | 145k | 29.91 | |
| Chimerix (CMRX) | 2.3 | $4.3M | 780k | 5.54 | |
| Aquinox Pharmaceuticals | 2.2 | $4.1M | 310k | 13.36 | |
| Adamas Pharmaceuticals | 2.1 | $4.1M | 250k | 16.41 | |
| Immunomedics | 2.0 | $3.9M | 1.2M | 3.25 | |
| Inotek Pharmaceuticals Corp conv | 2.0 | $3.8M | 400k | 9.48 | |
| Xenon Pharmaceuticals (XENE) | 1.7 | $3.3M | 410k | 8.10 | |
| Prothena (PRTA) | 1.6 | $3.0M | 50k | 59.98 | |
| Edge Therapeutics | 1.5 | $2.9M | 280k | 10.41 | |
| Loxo Oncology | 1.5 | $2.9M | 110k | 26.18 | |
| Trillium Therapeutics, Inc. Cmn | 1.4 | $2.6M | 175k | 14.78 | |
| Zogenix | 1.3 | $2.5M | 220k | 11.43 | |
| Cytomx Therapeutics (CTMX) | 1.3 | $2.5M | 160k | 15.68 | |
| Ultragenyx Pharmaceutical (RARE) | 1.3 | $2.5M | 35k | 70.94 | |
| Proteostasis Therapeutics In | 1.2 | $2.4M | 152k | 15.59 | |
| Lion Biotechnologies | 1.2 | $2.3M | 280k | 8.23 | |
| Corium Intl | 1.2 | $2.3M | 400k | 5.63 | |
| Amarin Corporation (AMRN) | 1.2 | $2.2M | 700k | 3.19 | |
| Neuroderm Ltd F | 0.9 | $1.8M | 99k | 18.49 | |
| Nabriva Therapeutics | 0.9 | $1.7M | 240k | 7.05 | |
| Innocoll Hldgs | 0.8 | $1.6M | 269k | 5.81 | |
| Affimed Therapeutics B V | 0.6 | $1.2M | 430k | 2.78 | |
| Intec Pharma | 0.5 | $1.0M | 175k | 5.88 | |
| Tenax Therapeutics | 0.5 | $905k | 390k | 2.32 | |
| Portola Pharmaceuticals | 0.4 | $795k | 35k | 22.71 | |
| Abeona Therapeutics | 0.3 | $600k | 100k | 6.00 | |
| AMAG Pharmaceuticals | 0.2 | $368k | 15k | 24.53 | |
| Biolinerx Ltd-spons | 0.1 | $288k | 250k | 1.15 | |
| DepoMed | 0.0 | $41k | 1.7k | 24.85 |
